Lung Cancer Care

What it is

Lung cancer is broadly divided into non-small cell lung cancer, the more common type, and small cell lung cancer. Assessment usually involves a CT scan, often a PET-CT, a biopsy and, for non-small cell lung cancer, tests on the tumour (for example EGFR, ALK or PD-L1) that can influence which treatments are relevant.

Depending on the type, stage and test results, a plan may include surgery, radiotherapy (including stereotactic radiotherapy for some small tumours), chemotherapy, immunotherapy or targeted therapy, alone or in combination. Plans are usually agreed by a multidisciplinary thoracic tumour board.

Lung function and general fitness also matter, especially when surgery is being considered. All decisions are made by the treating team after a full review.

How the pathway is coordinated

1. 01

   Consultation

   You contact a coordinator and describe what you would like reviewed. We explain what we can and cannot do: ELAVIA Global coordinates care and does not give medical advice or treatment.

2. 02

   Review of your records and scans

   With your consent, your reports, imaging and pathology are shared securely with an oncologist at an independent partner clinic. Original scan files or pathology slides may need to be re-reviewed, or some tests repeated.

3. 03

   Plan by the treating oncologist

   A thoracic oncology team reviews the scans, pathology and test results and explains the general approach it would recommend. Additional tests, such as further molecular testing or brain imaging, may be needed first.

4. 04

   Treatment at a partner clinic

   If you choose to have part of your care at a partner clinic, it is delivered by its thoracic surgery and oncology teams, with the coordinator arranging the practical details around each step.

5. 05

   Follow-up

   You receive written reports to take home. Ongoing follow-up is usually arranged with your oncologist at home, and the coordinator helps share records between the teams.

Who it may apply to

• People with a lung nodule or mass on a scan who would like the findings reviewed
• People with a new lung cancer diagnosis who would like an additional expert view
• People whose tumour has been, or may need to be, tested for molecular markers

These are general examples only. Whether any test or treatment is appropriate is decided by a treating oncologist after examination, imaging and pathology review.

What to prepare

• Your most recent consultation letters and medical reports
• Imaging reports and, where possible, the original scan files (CT, MRI, PET-CT) as a download link or disc
• Pathology and biopsy reports, including any receptor or molecular test results
• A list of treatments received so far, with dates, and your current medication
• Recent blood test results
• Chest CT and PET-CT images and reports, the biopsy report with any molecular or PD-L1 results, and recent lung function tests

Send copies and keep your originals. The reviewing team may ask for further records, or for some tests to be repeated.

How cost is confirmed

Cost depends on the diagnosis and treatment plan and is confirmed in a written quote after consultation.

Common questions